Clinical trial

Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer

NCT01969955

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2013-09-01

PhasePHASE2

Study timeline

Study start (unknown)2013-09-01Date precision: month

Registry last updated2014-04-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Squamous Cell Carcinoma of Lungunresolved

Interventions

nanoparticle albumin-bound paclitaxelDRUG

Sponsors & collaborators

Chinese Academy of Medical Scienceslead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01969955 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.